PharmExec Blog
Follow Us
RSS
Bookstore
Monthly Archives: July 2009
Pfizer Joins Twitter Fray
Image via Wikipedia
The Internet was aflutter this week when word got out that Pfizer had taken the dive into Twitter, the micro blog site that’s being touted as the next big social media tool by some and a dying fad by others. Twitter works by allowing users to enter a 140-character-or-less tidbit of information on [...]
Posted in News Tagged brand, Comcast, Customer service, Novo Nordisk, On the Web, Pfizer, social media, Twitter 2 Comments
NHLBI Cans Sildenafil Study After Reports of Severe Pain
Image via Wikipedia
The National Heart, Lung, and Blood Institute (NHLBI) announced, on Tuesday, that it was ending a clinical study involving Pfizer’s Revatio (sildenafil), a hypertension treatment and the active ingredient in Viagra, due to safety concerns.
According to a lengthy release from the Institute, researchers realized that the patients in the study for the treatment [...]
Hamburg Shifts Boxes at FDA
Image via Wikipedia
Typical of new administrations, FDA commissioner Margaret Hamburg is moving around some staff functions and bringing in new faces, but holding off on major reorganizational changes at the agency. There will be a new “food czarâ€â€”a deputy commissioner of food—but not a comparable official in charge of drugs, biologics and medical devices. Hamburg [...]
Authorized Generics Agreements to Increase
Image by :: Wendy :: via Flickr
The number of authorized generics (AG) agreements is likely to grow as pharma continues to converge with generics companies, a new report from Datamonitor claims. AG agreements are considered more ‘potent’ in the US market because market exclusivity is awarded to first-to-file generics companies, but detractors among the generics-producing [...]
Posted in Global, News, Regulatory Tagged analysis, branded pharma, Datamonitor, generics, patents, Pharmaceuticals, Regulatory 1 Comment
GSK Signs $120M Deal to Market DMab Overseas